For Immediate Release
June 1, 2005

Roswell Park Cancer Institute Awarded $2.1 Million In Grants

BUFFALO, NY – National Institutes of Health grants totaling $2,174,101 have been awarded to six members of the Roswell Park Cancer Institute faculty.

• Candace Johnson, PhD, Department of Pharmacology & Therapeutics, a $477,581 grant to study the “Anti-tumor Mechanisms & Therapeutic Effects of Vitamin D.” 
• Hiroki Nagase, MD, PhD, Department of Cancer Genetics, a $404,460 grant for the “Analysis and Identification of Skin Cancer in Mice.” 
• Carl Porter, PhD, Department of Pharmacology & Therapeutics, a $390,215 grant to evaluate the “Antiproliferative Potential of Polyamine Catabolism.”
• Donald Trump, MD, Department of Medicine, a grant for $339,915 for the “Evaluation of CYP24 as a Target for Enhancing Vitamin D.”
• Elizabeth Repasky, PhD, Department of Immunology, a $288,360 grant to study “Thermal Regulation of the Anti-Tumor Immune Response.”
• Protul Shrikant, PhD, Department of Immunology, a $273,570 grant to investigate "Regulation of Antigen-Specific CD8+ T Cell Responses by IL-21.”

Roswell Park Cancer Institute, founded in 1898, is the nation’s first cancer research, treatment and education center and is the only National Cancer Institute- designated comprehensive cancer center in Upstate New York.  RPCI is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers.  For more information, visit the RPCI website at www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.

-30-